Sobi to refile Gamifant following CHMP rejection
admin 27th July 2020 Uncategorised 0The company’s peak sales forecast of more than $500 million remains unchanged
More: Sobi to refile Gamifant following CHMP rejection
Source: News
The company’s peak sales forecast of more than $500 million remains unchanged
More: Sobi to refile Gamifant following CHMP rejection
Source: News
© 1994 - 2024 B.M. Pharmaceuticals